CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise President and CEO acquired 10,375 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 1,590 shares at $1.69 ($2,687)
- 4 Option exercise General Counsel acquired 2,688 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy President and CEO bought 15,000 shares at an average $1.18 ($17,646)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy President and CEO bought 15,000 shares at an average $1.11 ($16,703)
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
Page 7 of 38 · 755 filings